These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11108884)

  • 1. Preclinical experience with two selective progesterone receptor modulators on breast and endometrium.
    Kloosterboer HJ; Deckers GH; Schoonen WG; Hanssen RG; Rose UM; Verbost PM; Hsiu JG; Williams RF; Hodgen GD
    Steroids; 2000; 65(10-11):733-40. PubMed ID: 11108884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORG 33628 and ORG 31710 to control vaginal bleeding in progestin-only contraceptive regimens.
    Verbost PM; Hanssen RG; Korver GH; Mulders TM
    Semin Reprod Med; 2005 Feb; 23(1):101-11. PubMed ID: 15714394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of progesterone antagonists and progesterone receptor modulators in contraception.
    Spitz IM; Van Look PF; Coelingh Bennink HJ
    Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RU486-induced menses in cynomolgus monkeys: uniformity of endometrial sloughing.
    Chillik CF; Hsiu JG; Acosta AA; van Uem JF; Hodgen GD
    Fertil Steril; 1986 May; 45(5):708-12. PubMed ID: 3009235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.
    Kloosterboer HJ; Deckers GH; Schoonen WG
    Hum Reprod; 1994 Jun; 9 Suppl 1():47-52. PubMed ID: 7962469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of a new selective antiprogestagen: Org 33628.
    Kloosterboer HJ; Deckers GH; de Gooyer ME; Dijkema R; Orlemans EO; Schoonen WG
    Ann N Y Acad Sci; 1995 Jun; 761():192-201. PubMed ID: 7625721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.
    Brache V; Sitruk-Ware R; Williams A; Blithe D; Croxatto H; Kumar N; Kumar S; Tsong YY; Sivin I; Nath A; Sussman H; Cochon L; Miranda MJ; Reyes V; Faundes A; Mishell D
    Contraception; 2012 May; 85(5):480-8. PubMed ID: 22176795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques.
    Slayden OD; Chwalisz K; Brenner RM
    Hum Reprod; 2001 Aug; 16(8):1562-74. PubMed ID: 11473944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
    Dao B; Vanage G; Li XJ; Bardin CW; Koide SS
    Contraception; 1997 Jan; 55(1):35-40. PubMed ID: 9013059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol.
    Xiao E; Xia-Zhang L; Shanen D; Ferin M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2233-8. PubMed ID: 9215299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.
    Healy DL; Baulieu EE; Hodgen GD
    Fertil Steril; 1983 Aug; 40(2):253-7. PubMed ID: 6307760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys.
    Ishwad PC; Katkam RR; Hinduja IN; Chwalisz K; Elger W; Puri CP
    Contraception; 1993 Jul; 48(1):57-70. PubMed ID: 8403906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.